Biotechnology News

October 2, 2012

BOSTON--(BUSINESS WIRE)--Governor Patrick joined ARGO Medical Technologies and the Massachusetts Life Sciences Center to announce the Israeli-founded exoskeleton technology leader chose Massachusetts as its US headquarters.

October 2, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. (“Biomet”) today announced the early tender results of the previously announced cash tender offer (the “Tender Offer”) for any and all of its 10% Senior Notes due 2017 (CUSIP Nos. 090613AC4; 550785AA7;...

October 2, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. today announced the completion of its previously announced offering of $825 million aggregate principal amount of senior notes due 2020 (the “Additional Senior Notes”), at an issue price of 105.000%...

October 2, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Parkinson’s Costs Expected to Rise

October 2, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--CCGroup is proud to be the first company to release a free grouper of medical condition episodes to the public.

October 2, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega announces the introduction of a novel cytotoxicity assay that can be used on cell cultures for up to 72 hours...

October 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--New research by Cutting Edge Information aims to help call center managers assess their operations, increase efficiency and generate a bigger impact.

October 2, 2012

WESTCHESTER, N.Y.--(BUSINESS WIRE)--As part of Healthy Skin Month October, 2012, ENT and Allergy Associates, LLP (ENTA), the largest ear, nose, throat, allergy and audiology practice in the tri-state area, is once again helping to generate...

October 2, 2012

SAN BRUNO, Calif.--(BUSINESS WIRE)--A San Francisco Bay Area Clinical Research Organization (CRO) named PRC Clinical provides project management, clinical monitoring, data management, safety and site payment services joins BayBio.

October 2, 2012

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--TYRX, Inc. has been named to the FierceMedicalDevices “Fierce 15” list, designating it as one of the leading medical device and diagnostic companies of 2012.

October 2, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems has been selected as a member of the Fierce 15 MedicalDevices award for its game-changing diagnostic technology, capable of direct detection of any immunological or molecular target.

October 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company has been named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device...

October 2, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced that the company has been named to the FierceMedicalDevices “Fierce 15” list, designating...

October 2, 2012

LYON & GRENOBLE, France--(BUSINESS WIRE)--Aguettant, a French pharmaceutical company, and PX’Therapeutics, Contract Manufacturing Organization dedicated to the development of recombinant proteins, join forces to boost their activities

October 2, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--StatLink® Systems, a Memphis-based process management company, has announced the purchase of AccuRead Endoscopy, a California-based capsule endoscopy reading company.

October 2, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the multiple myeloma drug market will experience significant growth, increasing...

October 2, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that, nine months after commercial availability in the US, Regeneron’s Eylea captures 13...

October 2, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--EndoGastric Solutions Completes Enrollment for Clinical Trial that compares transoral fundoplication to medical therapy such as PPIs for the treatment of GERD.

October 2, 2012

HAZELWOOD, Mo.--(BUSINESS WIRE)--Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), today announced that it has completed its acquisition of CNS Therapeutics, Inc. for approximately $100 million. CNS is a privately held specialty...

October 2, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, a world industry leader in drug development and advanced delivery technologies, today announced the establishment of a global alliance with PAREXEL International Corporation to help...

October 2, 2012

BOSTON--(BUSINESS WIRE)--Third Rock Ventures, LLC, a venture capital firm focused on building life sciences companies, today announced that Felix W. Frueh, Ph.D., has joined Third Rock as an entrepreneur-in-residence (EIR). As an EIR, Dr. Frueh...

October 2, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Drug companies employ an average of 28 full-time equivalents (FTEs) around the world to oversee their investigator-initiated trial (IIT) operations, according to study by Cutting Edge Information.

October 2, 2012

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Metagenics Announces Free Educational Webinar October 24 on the Role of Medical Foods in Managing Chronic Diseases

October 2, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it has appointed Karin L. Walker, CPA, as vice president of finance and chief accounting officer. Ms. Walker has over two decades of financial management...

October 2, 2012

MILFORD, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its Thermo Scientific Mass Spectrometric Immunoassay (MSIA) pipette tips, a collection of immunoaffinity sample preparation...

October 2, 2012

SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn has introduced iExaminer™—a product that allows healthcare providers to capture, store, send and retrieve images from a Welch Allyn PanOptic™ Ophthalmoscope using an iPhone™ 4 or 4S.

October 2, 2012

WOBURN, Mass. & TOKYO--(BUSINESS WIRE)--ArQule and Daiichi Sankyo announce discontinuation of Phase 3 MARQUEE trial in non-small cell lung cancer.

October 2, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted...

October 2, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an...

October 2, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that its partner Pfizer Inc. (NYSE: PFE) achieved a development milestone related to its undisclosed Consumer Healthcare product. This development milestone in...

October 2, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it plans to release its third quarter 2012 financial results on Monday, November 5th, 2012 before the market opens. Bruker will then host an operator-...

October 2, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule Company is No Longer Contemplating a Reverse Stock Split.

October 2, 2012

BERLIN--(BUSINESS WIRE)--EX US & UK.Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company today announced results from a large Phase III study and three pooled analyses of Phase III data presented at the 48th European Association...

October 2, 2012

DENVER--(BUSINESS WIRE)--The United States Attorney's Office (USAO) for St. Louis recently informed DaVita that it has completed its investigation and is not taking any action against the company.

October 2, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. announces the enrollment of the first patient in the Phase 1B clinical trial of Aduro’s CRS-207 therapeutic cancer vaccine combined with chemotherapy in patients newly diagnosed with...

October 2, 2012

FREDERICK, Md.--(BUSINESS WIRE)--Akonni Biosystems Awarded $280,000 National Institutes of Health (NIH) Grant to Develop Benchtop Nucleic Acid Isolation Instrument

October 2, 2012

BERLIN--(BUSINESS WIRE)--Janssen Research & Development, LLC (Janssen) today announced that use of the investigational medicine canagliflozin substantially lowered blood glucose levels when used as add-on therapy in patients on insulin...

October 2, 2012

BERLIN--(BUSINESS WIRE)--EX US & UK.Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company today announced results of a pooled analysis of Phase IIb data for empagliflozin*, their investigational inhibitor of the sodium glucose co...

October 2, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent International AB (OMXS:BINV) announces today that the company has decided to focus its operations with the aim of achieving self-financing of the business before external costs for future...

October 2, 2012

MUNICH--(BUSINESS WIRE)--Brainlab today announced the release of Buzz™ Digital OR, a major step forward in information integration for the surgical suite. Buzz encompasses a vast spectrum, from pure DICOM viewing to complete digital OR...

October 2, 2012

SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn has introduced the iExaminer™—a product that allows healthcare providers to capture, store, send and retrieve images from a Welch Allyn PanOptic™ Ophthalmoscope using an iPhone™ 4 or 4S.

October 2, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--Announcement of Boehringer Ingelheim hepatitis C data to be presented at The Liver Meeting (AASLD) next month. Includes data in difficult to treat patients.

October 2, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals presented final phase 2 melanoma data at ESMO; implications for special protocol assessment for Phase 3 trial of PV-10

October 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme announced that ENGAGE, the first Phase 3 trial of its investigational oral therapy, eliglustat tartrate, in previously untreated patients with Gaucher disease type 1, met its primary endpoint.

October 2, 2012

MARCY L'ETOILE, France & HENNIGSDORF, Germany--(BUSINESS WIRE)--bioMérieux and Thermo Fisher Scientific Inc., the world leader in serving science, today announced they have renewed their non-exclusive, long-term, royalty-bearing agreement for...

October 1, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN) confirms that U.S. District Judge Andrew J. Guilford has entered an order providing that the injunction against Merz Aesthetics prohibiting it from, among other things, selling or...

October 1, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--ELIQUIS® (apixaban) Demonstrates Consistent Reductions in Stroke and Systemic Embolism, Major Bleeding and Mortality Compared to Warfarin

October 1, 2012

INDIANAPOLIS--(BUSINESS WIRE)--In a ruling on September 28, 2012 in the U.S. District Court, Middle District of North Carolina, two affiliates of Dow AgroSciences received a $5.3 million award against Bayer Bioscience.